venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data

from individual patients. BMJ 2009;338.

267. Partsch H, Damstra R, Tazelaar D, et al. Multicentre, randomised controlled trial of four-layer

bandaging versus short-stretch bandaging in the treatment of venous leg ulcers. Vasa 2001;30:108–

113.

268. van Gent WB, Hop WC, van Praag MC, et al. Conservative versus surgical treatment of venous leg

ulcers: a prospective, randomized, multicenter trial. J Vasc Surg 2006;44:563–571.

269. Gohel MS, Barwell JR, Taylor M, et al. Long term results of compression therapy alone versus

compression plus surgery in chronic venous ulceration (Eschar): randomised controlled trial. BMJ

2007;335:83.

270. Mauck KF, Asi N, Undavalli C, et al. Systematic review and meta-analysis of surgical interventions

versus conservative therapy for venous ulcers. J Vasc Surg 2014;60:60S–70S.

271. Erickson CA, Lanza DJ, Karp DL, et al. Healing of venous ulcers in an ambulatory care program:

the roles of chronic venous insufficiency and patient compliance. J Vasc Surg 1995;22:629–636.

272. Nicoloff AD, Moneta GL, Porter JM. Compression treatment of chronic venous insufficiency. In:

Gloviczki P, Yao JS, eds. Handbook of Venous Disorders. 2nd ed. London: Arnold; 2001:303–308.

273. Nelson EA, Mani R, Thomas K, et al. Intermittent pneumatic compression for treating venous leg

ulcers. Cochrane Database Syst Rev. 2011;(2):CD001899.

274. Coleridge-Smith P, Sarin S, Hasty J, Scurr JH. Sequential gradient pneumatic compression enhances

venous ulcer healing. A randomized trial. Surgery 1990;108:871–875.

275. Nikolovska S, Arsovski A, Damevska K, et al. Evaluation of two different intermittent pneumatic

compression cycle settings in the healing of venous ulcers: a randomized trial. Med Sci Moni

2005;11:CR337–CR343.

276. O’Donnell TF, Passman MA, Marston WA, et al. Management of venous leg ulcers: clinical practice

guidelines of the Society For Vascular Surgery® and the American Venous Forum. J Vasc Surg

2014;60:3S–59S.

277. Brown A. Life-style advice and self-care strategies for venous leg ulcer patients: what is the

evidence? J Wound Care 2012;21:342–350.

278. Kan YM, Delis KT. Hemodynamic effects of supervised calf muscle exercise in patients with venous

leg ulceration: a prospective controlled study. Arch Surg 2001;136:1364–1369.

279. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based

systematic review. Arch Dermatol 1998;134: 1356–1360.

280. Martinez Zapata MJ, Bonfill Cosp X, Moreno RM, et al. Phlebotonics for venous insufficiency. The

Cochrane Library. 2005;(3):CD003229.

281. Jull A, Arroll B, Parag V, Waters J. Pentoxifylline for treating venous leg ulcers. Cochrane Database

Syst Rev. 2012;12:CD001733. doi: 10.1002/ 14651858.CD001733.pub3.

282. Dale J, Ruckley C, Harper D, et al. Randomised, double blind placebo controlled trial of

pentoxifylline in the treatment of venous leg ulcers. BMJ 1999;319:875–878.

283. Falanga V, Fujitani RM, Diaz C, et al. Systemic treatment of venous leg ulcers with high doses of

pentoxifylline: efficacy in a randomized, placebo-controlled trial. Wound Repair Regen 1999;7:208–

213.

284. Alinovi A, Bassissi P, Pini M. Systemic administration of antibiotics in the management of venous

ulcers. A randomized clinical trial. J Am Acad Dermatol 1986;15:186–191.

285. Schraibman IG. The significance of beta-haemolytic streptococci in chronic leg ulcers. Ann Royal

Coll Surg Engl 1990;72:123.

286. Kilburn SA, Featherstone P, Higgins B, et al. Interventions for cellulitis and erysipelas. Cochrane

Database Syst Rev. 2010;(6):CD004299.

287. Hohenleutner U, Walther T, Wenig M, et al. Leg telangiectasia treatment with a 1.5 ms pulsed dye

laser, ice cube cooling of the skin and 595 vs 600 nm: preliminary results. Lasers Surg Med.

1998;23:72–78.

288. Bernstein EF, Kornbluth S, Brown DB, et al. Treatment of spider veins using a 10 millisecond pulseduration frequency-doubled neodymium YAG laser. Dermatol Surg 1999;25:316–320.

289. Villavicencio JL. Sclerotherapy guidelines. In: Gloviczki P, Yao JS, eds. Handbook of Venous

Disorders. 2nd ed. New York: Arnold; 2001:253–266.

2834

290. Kern P, Ramelet AA, Wutschert R, et al. Single-blind, randomized study comparing chromated

glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.

Dermatol Surg 2004;30:367–372; discussion 372.

291. Alos J, Carreno P, Lopez JA, et al. Efficacy and safety of sclerotherapy using polidocanol foam: a

controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101–107.

292. Belcaro G, Cesarone MR, Di Renzo A, et al. Foam-sclerotherapy, surgery, sclerotherapy, and

combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (vedico

trial). Angiology 2003;54:307–315.

293. Miyazaki K, Nishibe T, Sata F, et al. Stripping operation with sclerotherapy for primary varicose

veins due to greater saphenous vein reflux: three-year results. World J Surg 2003;27:551–553.

294. Iwamoto S, Ikeda M, Kawasaki T, et al. Treatment of varicose veins: an assessment of

intraoperative and postoperative compression sclerotherapy. Ann Vasc Surg 2003;17:290–295.

295. Field C. Sclerosing solutions. In: Bergan JJ, ed. The Vein Book. Boston, MA: Elsevier Academic

Press; 2007:125–131.

296. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the

treatment of varicose veins. Dermatol Surg 2001;27: 58–60.

297. Hamel-Desnos C, Desnos P, Wollmann JC, et al. Evaluation of the efficacy of polidocanol in the

form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: Initial

results. Dermatol Surg 2003;29:1170–1175; discussion 1175.

298. Goldman M. Complications and adverse sequelae of sclerotherapy. In: Bergan JJ, ed. The Vein Book.

Boston, MA: Elsevier Academic Press; 2007: 139–155.

299. Guex JJ, Allaert FA, Gillet JL, et al. Immediate and midterm complications of sclerotherapy: report

of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005;31:123–

128; discussion 128.

300. Guex J. Complications and side-effects of foam sclerotherapy. Phlebology 2009;24:270–274.

301. Scultetus AH, Villavicencio JL, Kao TC, et al. Microthrombectomy reduces postsclerotherapy

pigmentation: multicenter randomized trial. J Vasc Surg 2003;38:896–903.

302. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon

dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830–836.

303. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N

Engl J Med 2008;358:1525–1526.

304. Bergan JJ. Varicose veins: hooks, clamps, and suction. Application of new techniques to enhance

varicose vein surgery. Semin Vasc Surg 2002;15: 21–26.

305. de Roos KP, Nieman FH, Neumann HA. Ambulatory phlebectomy versus compression sclerotherapy:

results of a randomized controlled trial. Dermatol Surg 2003;29:221–226.

306. Ramelet AA. Complications of ambulatory phlebectomy. Dermatol Surg 1997;23:947–954.

307. Smith SR, Goldman MP. Tumescent anesthesia in ambulatory phlebectomy. Dermatol Surg

1998;24:453–456.

308. Aremu MA, Mahendran B, Butcher W, et al. Prospective randomized controlled trial: conventional

versus powered phlebectomy. J Vasc Surg 2004;39:88–94.

309. Criado E, Lujan S, Izquierdo L, et al. Conservative hemodynamic surgery for varicose veins. Semin

Vasc Surg 2002;15:27–33.

310. Parés JO, Juan J, Tellez R, et al. Varicose vein surgery: stripping versus the Chiva method: a

randomized controlled trial. Ann Surg 2010;251:624–631.

311. Pittaluga P, Chastanet S, Rea B, et al. Midterm results of the surgical treatment of varices by

phlebectomy with conservation of a refluxing saphenous vein. J Vasc Surg 2009;50:107–118.

312. Raju S, Easterwood L, Fountain T, et al. Saphenectomy in the presence of chronic venous

obstruction. Surgery 1998;123:637–644.

313. Padberg FT, Pappas, PJ, Araki, CT. Hemodynamic and clinical improvement after superficial vein

ablation in primary combined venous insufficiency with ulceration. J Vasc Surg 1997;26:169.

314. Dalsing MC. Lower extremity varicose vein disease. In: Cameron JL, ed. Current Surgical Therapy.

7th ed. St Louis, MO: Mosby; 2001:992–998.

315. Dwerryhouse S, Davies B, Harradine K, et al. Stripping the long saphenous vein reduces the rate of

2835

reoperation for recurrent varicose veins: five-year results of a randomized trial. J Vasc Surg

1999;29:589–592.

316. Menyhei G, Gyevnár Z, Arato E, et al. Conventional stripping versus cryostripping: a prospective

randomised trial to compare improvement in quality of life and complications. Euro J Vasc Endovasc

Surg 2008;35:218–223.

317. Larson RH, Lofgren EP, Myers TT, et al. Long-term results after vein surgery. Study of 1,000 cases

after 10 years. Mayo Clin Proc 1974;49:114–117.

318. Winterborn RJ, Foy C, Earnshaw JJ. Causes of varicose vein recurrence: late results of a

randomized controlled trial of stripping the long saphenous vein. J Vasc Surg 2004;40:634–639.

319. Chandler JG, Pichot O, Sessa C, et al. Treatment of primary venous insufficiency by endovenous

saphenous vein obliteration. J Vasc Surg 2000;34:201.

320. Lurie F, Creton D, Eklof B, et al. Prospective randomized study of endovenous radiofrequency

obliteration (closure procedure) versus ligation and stripping in a selected patient population

(evolves study). J Vasc Surg 2003;38:207–214.

321. Navarro L, Min RJ, Bone C. Endovenous laser: a new minimally invasive method of treatment for

varicose veins–preliminary observations using an 810 nm diode laser. Dermatol Surg 2001;27:117–

122.